Alto Neuroscience Inc.
(ANRO)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | - | - | 210.00K |
Cost of Revenue | 373.00K | 342.00K | 145.00K |
Gross Profit | -373.00K | -342.00K | 65.00K |
Operating Income | -37.81M | -29.19M | -12.06M |
Interest Income | 2.35M | 114.00K | 2.00K |
Pretax Income | -36.30M | -27.71M | -9.19M |
Net Income | -36.30M | -27.71M | -9.19M |
Selling & General & Admin | 7.52M | 5.16M | 3.75M |
Research & Development | 30.29M | 23.69M | 8.37M |
Other Expenses | - | - | - |
Operating Expenses | 37.81M | 28.85M | 12.12M |
Interest Expense | 1.37M | - | - |
Selling & Marketing Expenses | - | -342.00K | -145.00K |
Cost & Expenses | 37.81M | 29.19M | 12.27M |
Income Tax | - | - | - |
Shares Outstanding (Basic) | 26.88M | 25.57M | 25.57M |
Shares Outstanding (Diluted) | 26.88M | 25.57M | 25.57M |
EPS (Basic) | -1.35 | -1.08 | -0.36 |
EPS (Diluted) | -1.35 | -1.08 | -0.36 |
EBITDA | -34.56M | -27.37M | -9.04M |
Depreciation & Amortization | 373.00K | 342.00K | 145.00K |